← FDA DRUG APPROVALS
FDA ANDA · ANDA220386
LACOSAMIDE ORAL SOLUTION
lacosamide oral
Sponsor: REGCON HOLDINGS
APPLICATION
ANDA220386
TYPE
ANDA
ORIGINAL APPROVAL
2026-01-29
LATEST ACTION
2026-01-29
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
LACOSAMIDEPrescription
LACOSAMIDE 10MG/ML · SOLUTION · ORAL
Approval history
2026-01-29UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.